Market Commentary     24-Mar-25
Mid-Session
Nifty trades near 23,550 mark; realty shares rally for 5th day
The key domestic indices traded with substantial gains in morning trade. The Nifty traded near 23,550 mark. Realty shares witnessed buying demand for the fifth consecutive trading session.

At 10:26 IST, the barometer index, the S&P BSE Sensex, added 647.43 points or 0.84% to 77,553.07. The Nifty 50 index advanced 198.25 points or 0.85% to 23,548.55.

The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 1.15% and the S&P BSE Small-Cap index added 1.29%.

The market breadth was strong. On the BSE, 2,760 shares rose and 998 shares fell. A total of 198 shares were unchanged.

Buzzing Index:

The Nifty Realty index jumped 1.85% to 879.55. The index surged 10.34% in the five consecutive trading sessions.

Brigade Enterprises (up 4.87%), Macrotech Developers (up 4.59%), Oberoi Realty (up 1.97%), Prestige Estates Projects (up 1.9%) and Phoenix Mills (up 1.59%), Mahindra Lifespace Developers (up 1.15%), Raymond (up 1.11%), Godrej Properties (up 0.81%) and DLF (up 0.34%) surged.

Stocks in Spotlight:

Biocon added 1.16% after the company’s wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine Bitartrate Injection.

RailTel Corporation of India surged 8.49% after the company announced that it had received a work order worth Rs 25.15 crore from Hindustan Petroleum Corporation (HPCL).

NCC added 2.21% after the company announced that it has received a Letter of Acceptance (LoA) worth Rs 1,480.34 crore from the Bihar Medical Services & Infrastructure Corporation.

Previous News
  Biocon surges on U.S. deal for Eylea copycat drug
 ( Hot Pursuit - 15-Apr-25   09:58 )
  Biocon Biologics inks a settlement and license agreement with Regeneron
 ( Corporate News - 15-Apr-25   09:29 )
  Biocon Biologics receives USFDA approval for Jobevne™ (Biosimilar Bevacizumab)
 ( Corporate News - 10-Apr-25   13:25 )
  Biocon unit gets U.S. FDA nod for cancer drug biosimilar
 ( Hot Pursuit - 10-Apr-25   11:07 )
  Board of Biocon approves CP issuance of Rs 600 cr
 ( Corporate News - 05-Apr-25   14:34 )
  Trishakti Industries wins order of Rs 6 cr from NCC
 ( Corporate News - 04-Apr-25   13:51 )
  Trishakti Inds secures Rs 6-cr order from NCC
 ( Hot Pursuit - 04-Apr-25   11:23 )
  Biocon to table results
 ( Corporate News - 03-Apr-25   09:49 )
  Biocon to convene board meeting
 ( Corporate News - 02-Apr-25   10:19 )
  Biocon’s board to mull fund raising plans on 4 April
 ( Hot Pursuit - 02-Apr-25   08:09 )
  RailTel Corp gains on bagging order worth Rs 163-cr from Ircon International
 ( Hot Pursuit - 01-Apr-25   09:55 )
Other Stories
  Sensex surges 1,440 pts; Nifty above 23,800 level; PSU bank shares climb for 4th day
  17-Apr-25   14:34
  Sensex soars 1,256 points, Nifty above 23,750; European mkt declines
  17-Apr-25   13:33
  Nifty trades near 23,650 mark; private bank shares rally for 4th day
  17-Apr-25   12:36
  Sensex, Nifty pare losses; metal shares lose sheen
  17-Apr-25   11:34
  Nifty trades tad below 22,400; IT shares decline
  17-Apr-25   10:31
  Indices edge lower in early trade; breadth negative
  17-Apr-25   09:37
  Nifty above 23,400 level; oil & gas stocks climb for 3rd day
  16-Apr-25   14:30
  Sensex, Nifty pare gains; European mkt decline; VIX slides 2.20%
  16-Apr-25   13:34
  Nifty tad above 23,350 mark; media shares rally for 3rd day
  16-Apr-25   12:36
  Barometers trade near flat line; IT shares decline
  16-Apr-25   11:36
Back Top